KalVista Pharmaceuticals ...
(KALV)
undefined
undefined%
At close: undefined
8.69
0.06%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | - | - | - | 12.69M | 12.69M | 16.13M | 8.39M | 1.50M | 2.13M | 1.80M | 415.00K | 1.54M |
Cost of Revenue | 86.17M | 802.00K | 743.00K | 651.00K | 40.19K | 35.02K | 18.24K | 12.67K | 14.66K | 8.29K | - | - |
Gross Profit | -86.17M | -802.00K | -743.00K | 12.04M | 12.65M | 16.09M | 8.38M | 1.49M | 2.12M | 1.80M | 415.00K | 1.54M |
Operating Income | -140.44M | -110.87M | -96.61M | -57.92M | -40.53M | -29.82M | -18.70M | -22.34M | -15.18M | -8.09M | -5.22M | -1.83M |
Interest Income | - | 2.23M | 1.09M | 903.00K | 1.83M | 1.40M | 82.00K | 36.00K | 50.00K | 19.00K | 2.00K | 1K |
Pretax Income | -135.10M | -92.91M | -82.34M | -46.24M | -29.24M | -20.69M | -15.80M | -18.60M | -11.44M | -7.23M | -5.68M | -2.05M |
Net Income | -126.64M | -74.85M | -68.51M | -44.49M | -29.12M | -20.82M | -15.80M | -18.60M | -11.44M | -7.23M | -5.68M | -2.05M |
Selling & General & Admin | 54.28M | 30.59M | 26.45M | 16.64M | 13.03M | 10.93M | 8.86M | 11.18M | 2.65M | 1.61M | 1.40M | 1.41M |
Research & Development | 86.17M | 80.28M | 70.17M | 41.29M | 40.19M | 35.02M | 18.24M | 12.67M | 14.66M | 8.29M | 4.23M | 1.96M |
Other Expenses | -86.17M | 15.64M | 14.72M | 9.93M | 9.83M | 7.68M | 4.39M | 2.33M | 2.03M | 844.00K | -59.00K | 35.00K |
Operating Expenses | 54.28M | 110.87M | 96.61M | 57.92M | 53.22M | 45.95M | 27.10M | 23.84M | 17.31M | 9.89M | 5.63M | 3.37M |
Interest Expense | - | - | 1.09M | - | - | - | - | - | - | - | 405.00K | 256.00K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 140.44M | 110.87M | 96.61M | 57.92M | 53.22M | 45.95M | 27.10M | 23.84M | 17.31M | 9.89M | 5.63M | 3.37M |
Income Tax | -8.45M | -18.05M | -13.83M | -1.75M | -124.00K | 124.00K | -1.33M | -5.11M | -5.41M | -863.00K | 462.00K | 220.00K |
Shares Outstanding (Basic) | 36.79M | 27.89M | 24.47M | 19.09M | 17.75M | 15.08M | 10.32M | 9.71M | 4.77M | 1.17M | 724.80K | 724.80K |
Shares Outstanding (Diluted) | 36.79M | 27.89M | 24.47M | 19.09M | 17.75M | 15.08M | 10.32M | 9.71M | 4.77M | 1.17M | 724.80K | 724.80K |
EPS (Basic) | -3.44 | -2.68 | -2.8 | -2.33 | -1.64 | -1.38 | -1.53 | -1.92 | -2.4 | -6.17 | -7.83 | -2.83 |
EPS (Diluted) | -3.44 | -2.68 | -2.8 | -2.33 | -1.64 | -1.38 | -1.53 | -1.92 | -2.4 | -6.17 | -7.83 | -2.83 |
EBITDA | -134.28M | -92.11M | -81.60M | -45.59M | -40.02M | -29.44M | -18.52M | -22.30M | -15.15M | -8.05M | -5.25M | -1.76M |
Depreciation & Amortization | 816.00K | 802.00K | 743.00K | 651.00K | 525.00K | 378.00K | 180.00K | 40.00K | 133.00K | 38.00K | 27.00K | 38.00K |